Stay updated on Inclisiran in Asian ASCVD: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Inclisiran in Asian ASCVD: Efficacy & Safety Clinical Trial page.

Latest updates to the Inclisiran in Asian ASCVD: Efficacy & Safety Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Revision: v3.4.2 was added to the history and the prior notice about government funding/operating status (v3.4.1) was removed. These are administrative UI/website maintenance changes and do not affect study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check21 days agoChange DetectedA government operating-status notice and a new revision tag (v3.4.1) were added to the history, while the previous tag (v3.4.0) was removed.SummaryDifference0.7%

- Check28 days agoChange DetectedUI updates include a new 'Show glossary' option, added explanations of color-coded additions and deletions, and a revision label updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedThe Record History page shows a new revision label: v3.3.4 replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe Record History now includes new entries for Study Status and Contacts/Locations on 2025-12-22 and 2025-12-30, and an older entry was removed on 2025-08-03.SummaryDifference0.5%

- Check63 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the Record History and the 'HHS Vulnerability Disclosure' link was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Inclisiran in Asian ASCVD: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inclisiran in Asian ASCVD: Efficacy & Safety Clinical Trial page.